BSECompany Update30 Jul 2026 · 30 Jul 2026, 03:05 pm
As Attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryBonus/Split
Eris Lifesciences Ltd has informed about the allotment of 4,816 equity shares at a premium of Rs. 450.04 per share under the ESOP-2017 Scheme, increasing the paid-up share capital from Rs. 13,85,78,489 to Rs. 13,85,83,305.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Attachments (1)
📄pdf
Download →
5807d356-6228-4236-8dfb-1d88c56176f8.pdf
View document text
Date: 30 July 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai- 400001 Bandra (E)
Mumbai-400051
Security Code: 540596 Symbol: ERIS
Dear Sir/Madam,
SUB: ALLOTMENT OF EQUITY SHARES PURSUANT TO ESOP-2017 SCHEME
It is hereby informed that an allotment of 4,816 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per
share has been made on July 30, 2026, pursuant to the exercise of options under the ESOP-2017 Scheme.
The paid-up share capital of the Company accordingly stands increased from Rs. 13,85,78,489/-
(13,85,78,489 equity shares of Re. 1/- each) to 13,85,83,305/- (13,85,83,305 equity shares of Re. 1/- each).
The Information may please be taken on records.
Thanking You.
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
ICSI Mem. No.: A26493